Zika Virus Is Sweeping Across Central And South America, And Is Likely To Soon Enter The US. The Implications Of The Outbreak Are Examined In This Report.

11 September 2018
Pharma

A new report by visiongain studies the Zika virus outbreak that is current spreading through Central and South America. These insights appear in The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market, published February 2016. Visiongain is a business information provider based in London, UK.

The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market examines the current effects of the Zika outbreak, as well as the structure, reproduction, and outbreak history of the virus. Evidence is mounting regarding the serious complications that can accompany Zika infection, and these are explored in depth in this report.

Efforts are underway to develop new diagnostic tools for use in diagnosing Zika virus infection at point-of-care facilities, as well as to develop a vaccine to combat the spread of the disease. To support the case for this, the global infectious disease diagnostics market is forecast from 2016 to 2026, as is the global human vaccines market. The companies engaged in these efforts and their potential prolso outlined.

The spread of Zika virus could have serious social and economic impacts, including issues regarding contraducts are aception and abortion. Tourism is a major driver of economic growth in a number of countries that are either experiencing active transmission of Zika, or are at serious risk of doing so. The effects the virus could have on this industry are far reaching, some of which could result in further exacerbation of the outbreak. Using our experience and sources, we have compiled a comprehensive report on the potential impacts of this virus.

Jack Evans, a pharmaceutical and medical devices industry analyst in visiongain, said: “As Zika virus continues to spread across the Central and South America, evidence mounts for the correlation between Zika and microcephaly, as well as Zika and GBS. The rapid spread of Zika coupled with possible complications and imminent entrance into as yet unaffected regions has prompted major pharmaceutical companies to begin vaccine development for the virus. However, vaccine development remains in the early stages with having only entered preclinical trials. The virus could have a significant social and economic impact, with tourism an important regional industry. The Summer Olympics are taking place in Brazil in 2016, and Zika virus may have an effect on attendance numbers.”

The Zika Virus Report: Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market adds to visiongain’s range of analytical reports on industries and markets in healthcare.
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@visiongainglobal.com
Tel: +44 (0) 20 7336 6100

Notes for Editors

If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain

Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.

Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read